McKesson reaffirms FY2027 adjusted EPS forecast of $44.20-$45.00

PUBT · 1d ago
McKesson reaffirms FY2027 adjusted EPS forecast of $44.20-$45.00
  • McKesson reaffirmed fiscal 2027 adjusted EPS guidance of $44.20 to $45.00.
  • Long-term adjusted EPS growth outlook maintained at 13% to 16%.
  • Guidance reiteration followed an agreement in principle to extend CVS Health pharmaceutical distribution partnership through June 2032.
  • Further guidance updates scheduled for the second-quarter fiscal 2027 earnings call on Nov. 4, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202610010803BIZWIRE_USPR_____20261001_BW569834) on October 01, 2026, and is solely responsible for the information contained therein.